Cramer: House Passes H.R. 6, the 21st Century Cures Act

Date: July 10, 2015
Location: Washington, DC

Today, Congressman Kevin Cramer joined a bi-partisan majority of the U.S. House of Representatives to pass H.R. 6, the 21st Century Cures Act. The bill passed by a vote of 344 -- 77 and now goes to the U.S. Senate for consideration. Congressman Cramer is a cosponsor of the act. This legislation would reauthorize the National Institutes of Health (NIH), focus efforts to increase strategic investments and medical research at the NIH, and modernize the approval and regulatory process for new drugs, biologics and medical devices at the Food and Drug Administration (FDA). On May 21, 2015, the bill passed the House Energy and Commerce Committee by a vote of 51 -- 0.

"America has historically been a leader in medical innovation and breakthroughs, but government rules and regulations threaten our leadership in health care innovation. Our goal must be to create a regulatory environment where American innovators are not at a competitive disadvantage to foreign companies. The 21st Century Cures Act speeds access to new medicines and treatments by applying the right incentives and taking a more thoughtful approach to product approvals. The bill protects current US medical and biomedical jobs while spurring the creation of new medical research companies. This legislation brings hope and medical treatments and cures to many patients and their families who have run out of options," said Cramer.


Source
arrow_upward